BioLineRx GAAP EPS of $0.00 beats by $0.07, revenue of $4.94M misses by $0.35M

by


  • BioLineRx press release (NASDAQ:BLRX): Q3 GAAP EPS of $0.00 beats by $0.07.
  • Revenue of $4.94M misses by $0.35M.
  • As of September 30, 2024, the company had cash, cash equivalents, and short-term bank deposits of $29.2 million.
  • Following the out-license to


Leave a Comment